About: Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 April 1989

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у квітні 1989 (uk) article scientifique publié en 1989 (fr) im April 1989 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'abril de 1989 (ast) scientific article published on 01 April 1989 (en)
publication date	wds:Q69296621-7FAB825F-BCA7-4F54-971B-54C5FAE8FBA2
publication date	1989-04-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q69296621-1D73E37C-84C2-4C0E-835E-26E1792E8CE7
language of work or name	English
author name string	wds:Q69296621-80896981-4373-4816-AF40-85DA3F1927E8 wds:Q69296621-B943F93C-F71A-4217-A9A3-98CF29E63324 wds:Q69296621-BC86C2F0-472A-4D50-94A5-3D6BA1AA5E13 wds:Q69296621-EA0494A7-964F-4F0B-9D6D-D07BCF722B43
author name string	J S Douglas G S Roubin S B King J Wilentz
rdfs:label	Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty (en) Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty (nl)
skos:prefLabel	Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty (en) Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty (nl)
name	Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty (en) Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty (nl)
author	wds:Q69296621-33953952-EEF6-4F2C-B61B-25D42F7B61BE
author	Stephen G. Ellis
title	wds:Q69296621-3294760F-88FA-4D54-9C90-AD9E96B30FE1
title	Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty (en)
page(s)	wds:Q69296621-30E2518E-16BA-416A-BA21-63DD2AFA40CC
page(s)	777-782
instance of	wds:Q69296621-39012D73-4F47-4648-937C-CB1AFDA179E8
instance of	scholarly article
main subject	wds:Q69296621-C29CDF45-287F-490D-8ABA-738DF5EB7F83 wds:Q69296621-E4F5A339-281B-46FE-B38A-339AE6FDAE84
main subject	angioplasty heparin
PubMed ID	wds:Q69296621-07651C81-56A6-4321-89F6-0AF312A1928B
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2522716
PubMed ID	2522716
published in	wds:Q69296621-47393359-97BD-4606-B3E8-F997AB3A8653
published in	American Heart Journal
issue	wds:Q69296621-51AE7EB6-45AA-474C-94DD-67263F4E4655
volume	wds:Q69296621-1B0589A0-3ED7-4F58-A817-BB5775B1FA4E
issue	4
volume	117
DOI	wds:Q69296621-82D7434F-272B-4E0C-950E-DC30B6423FE6
DOI	http://dx.doi.org/10.1016/0002-8703(89)90612-1
DOI	10.1016/0002-8703(89)90612-1
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q69296621
is cites work of	Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty. Results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial). Reduction of Restenosis After PTCA, E Safety of low dose heparin in elective coronary angioplasty Usefulness of intravenous enoxaparin for percutaneous coronary intervention in stable angina pectoris High dose rate intracoronary radiation for inhibition of neointimal formation in the stented and balloon-injured porcine models of restenosis: angiographic, morphometric, and histopathologic analyses Effect of direct thrombin inhibition with Bivalirudin (Hirulog) on restenosis after coronary angioplasty. Neointima formation in a restenosis model is suppressed in midkine-deficient mice Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment Management of restenosis after coronary intervention The comparative pathobiology of atherosclerosis and restenosis Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine model Restenosis after coronary angioplasty Modifiable risk factors for vascular access site complications in the IMPACT II Trial of angioplasty with versus without eptifibatide. Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis. Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty Sustained-release local hirulog therapy decreases early thrombosis but not neointimal thickening after arterial stenting Low-molecular-weight heparin (reviparin) reduces the incidence of femoropopliteal in-stent stenosis: preliminary results of an ongoing study. Inhibition of thrombin attenuates stenosis after arterial injury in minipigs Critical analysis of coronary artery bypass graft surgery: a 30-year journey Restenosis--an open file Effect of lovastatin on intimal hyperplasia after balloon angioplasty: A study in an atherosclerotic hypercholesterolemic rabbit Restenosis following coronary angioplasty Unfractionated versus fractionated heparin for percutaneous coronary intervention Minimal heparinization in coronary angioplasty—how much heparin is really warranted? Experimental models of coronary artery restenosis Adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene inhibits vascular smooth muscle cell proliferation and neointima formation following balloon angioplasty of the rat carotid artery Mechanisms of angioplasty and stent restenosis: implications for design of rational therapy Sustained release of heparin from polymeric particles for inhibition of human vascular smooth muscle cell proliferation Characterization of a positron emitting V48 nitinol stent for intracoronary brachytherapy Surface modification of polyethylene balloon catheters for local drug delivery Risk factors, interventions and therapeutic agents in the prevention of atherosclerosis-related ischaemic diseases Pharmacological approaches to the prevention of restenosis after coronary angioplasty Towards the prevention of vein graft failure Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the Holy Grail? (Part II). Low molecular weight heparin (enoxaparin) reduces restenosis after iliac angioplasty in the hypercholesterolemic rabbit Cellular biology of human intimal hyperplastic stenosis Downregulation of the ERK 1 and 2 mitogen activated protein kinases using antisense oligonucleotides inhibits proliferation of porcine vascular smooth muscle cells Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury Tissue average binding and equilibrium distribution: an example with heparin in arterial tissues Thrombin activation and late restenosis after percutaneous transluminal coronary angioplasty Heparin dosing in patients undergoing coronary intervention Postangioplasty restenosis followed with magnetic resonance imaging in an atherosclerotic rabbit model Restenosis following coronary angioplasty: clinical presentations and therapeutic options The development of interventional cardiology Early mobilization after protamine reversal of heparin following implantation of phosphorylcholine-coated stents in totally occluded coronary arteries Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment Local infusion of heparin reduces anastomotic neointimal hyperplasia in aortoiliac expanded polytetrafluoroethylene bypass grafts in baboons Use of the perforated balloon catheter to infuse marker substances into diseased coronary artery walls after experimental postmortem angioplasty Adenoviral-mediated gene transfer of a constitutively active form of the retinoblastoma gene product attenuates neointimal thickening in experimental vein grafts Human recombinant tissue-factor pathway inhibitor prevents the proliferation of cultured human neonatal aortic smooth muscle cells Local heparin delivery prior to coronary stent implantation: acute and six-month clinical and angiographic results

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software